|
|
|
Insider
Information: |
Mubadala Development Co Pjsc |
Relationship: |
|
City: |
Abu Dhabi, |
State: |
C0 |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
60,175,111 |
|
Indirect Shares
|
119,187,709 |
|
|
Direct
Value |
$556,619,777 |
|
|
Indirect Value
|
$16,186,653,453 |
|
|
Total
Shares |
179,362,820 |
|
|
Total
Value |
$16,743,273,229 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
27
|
0
|
Stock
price went up :
|
10
|
0
|
Stock
price went down : |
17
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-12.4%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Advanced Micro Devices Inc |
AMD |
Director, 10% Owner |
|
0 |
2017-03-03 |
96,906,166 |
Premium* |
|
Recursion Pharmaceuticals, Inc. |
RXRX |
10% Owner |
2021-04-16 |
0 |
2023-03-02 |
20,048,796 |
Premium* |
|
Virgin Orbit Holdings, Inc |
VORB |
10% Owner |
2021-12-30 |
60,175,111 |
|
0 |
Premium* |
|
Endeavor Group Holdings, Inc. |
EDR |
|
|
0 |
2024-04-02 |
2,232,747 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VORB |
Virgin Orbit Holdings, In... |
10% Owner |
|
2021-12-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
60,175,111 |
|
% |
|
RXRX |
Recursion Pharmaceuticals... |
10% Owner |
|
2021-04-16 |
4 |
B |
$18.00 |
$49,999,986 |
I/I |
2,777,777 |
2,777,777 |
1.5 |
- |
|
RXRX |
Recursion Pharmaceuticals... |
10% Owner |
|
2021-04-20 |
4 |
A |
$0.00 |
$0 |
I/I |
13,026,009 |
8,740,917 |
0 |
- |
|
RXRX |
Recursion Pharmaceuticals... |
10% Owner |
|
2022-10-27 |
4 |
A |
$9.80 |
$24,999,996 |
I/I |
2,551,020 |
11,291,937 |
0 |
- |
|
RXRX |
Recursion Pharmaceuticals... |
10% Owner |
|
2022-12-23 |
4 |
B |
$7.52 |
$754,421 |
I/I |
100,378 |
11,392,315 |
1.5 |
% |
|
RXRX |
Recursion Pharmaceuticals... |
10% Owner |
|
2022-12-27 |
4 |
B |
$7.24 |
$1,054,404 |
I/I |
145,652 |
11,537,967 |
1.5 |
% |
|
RXRX |
Recursion Pharmaceuticals... |
10% Owner |
|
2022-12-28 |
4 |
B |
$7.18 |
$511,898 |
I/I |
71,299 |
11,609,266 |
1.5 |
% |
|
RXRX |
Recursion Pharmaceuticals... |
10% Owner |
|
2022-12-29 |
4 |
B |
$7.71 |
$652,774 |
I/I |
84,622 |
11,693,888 |
1.5 |
% |
|
RXRX |
Recursion Pharmaceuticals... |
10% Owner |
|
2022-12-30 |
4 |
B |
$7.55 |
$753,622 |
I/I |
99,754 |
11,793,642 |
1.5 |
% |
|
RXRX |
Recursion Pharmaceuticals... |
10% Owner |
|
2023-01-03 |
4 |
B |
$7.50 |
$1,063,011 |
I/I |
141,646 |
11,935,288 |
1.5 |
% |
|
RXRX |
Recursion Pharmaceuticals... |
10% Owner |
|
2023-01-04 |
4 |
B |
$7.80 |
$716,877 |
I/I |
91,892 |
12,027,180 |
1.5 |
% |
|
RXRX |
Recursion Pharmaceuticals... |
10% Owner |
|
2023-01-05 |
4 |
B |
$7.38 |
$590,554 |
I/I |
80,035 |
12,107,215 |
1.5 |
% |
|
RXRX |
Recursion Pharmaceuticals... |
10% Owner |
|
2023-01-06 |
4 |
B |
$7.41 |
$510,611 |
I/I |
68,953 |
12,176,168 |
1.5 |
% |
|
RXRX |
Recursion Pharmaceuticals... |
10% Owner |
|
2023-01-09 |
4 |
B |
$7.64 |
$580,839 |
I/I |
76,046 |
12,252,214 |
1.5 |
% |
|
RXRX |
Recursion Pharmaceuticals... |
10% Owner |
|
2023-01-10 |
4 |
B |
$7.72 |
$536,846 |
I/I |
69,518 |
12,321,732 |
1.5 |
% |
|
RXRX |
Recursion Pharmaceuticals... |
10% Owner |
|
2023-01-25 |
4 |
B |
$7.88 |
$193,267 |
I/I |
24,526 |
12,346,258 |
1.5 |
% |
|
RXRX |
Recursion Pharmaceuticals... |
10% Owner |
|
2023-01-26 |
4 |
B |
$7.99 |
$63,006 |
I/I |
7,886 |
12,354,144 |
1.5 |
% |
|
RXRX |
Recursion Pharmaceuticals... |
10% Owner |
|
2023-02-01 |
4 |
B |
$7.97 |
$4,782 |
I/I |
600 |
12,354,744 |
1.42 |
% |
|
RXRX |
Recursion Pharmaceuticals... |
10% Owner |
|
2023-02-10 |
4 |
B |
$7.98 |
$87,808 |
I/I |
11,000 |
12,365,744 |
1.5 |
% |
|
RXRX |
Recursion Pharmaceuticals... |
10% Owner |
|
2023-02-13 |
4 |
B |
$7.97 |
$258,837 |
I/I |
32,474 |
12,398,218 |
1.5 |
% |
|
RXRX |
Recursion Pharmaceuticals... |
10% Owner |
|
2023-02-14 |
4 |
B |
$7.95 |
$50,060 |
I/I |
6,300 |
12,404,518 |
1.5 |
% |
|
RXRX |
Recursion Pharmaceuticals... |
10% Owner |
|
2023-02-16 |
4 |
B |
$7.90 |
$337,043 |
I/I |
42,682 |
12,447,200 |
1.5 |
% |
|
RXRX |
Recursion Pharmaceuticals... |
10% Owner |
|
2023-02-17 |
4 |
B |
$7.71 |
$488,986 |
I/I |
63,382 |
12,510,582 |
1.5 |
% |
|
RXRX |
Recursion Pharmaceuticals... |
10% Owner |
|
2023-02-21 |
4 |
B |
$7.74 |
$731,126 |
I/I |
94,418 |
12,605,000 |
1.5 |
% |
|
RXRX |
Recursion Pharmaceuticals... |
10% Owner |
|
2023-02-22 |
4 |
B |
$7.83 |
$399,016 |
I/I |
50,941 |
12,655,941 |
1.5 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|